A volounteer for Clinical trials of one of the most advanced experimental Covid-19 vaccines, which is being developed by pharmaceutical company AstraZeneca and Oxford University, has developed a strange and unexplained illness leading to a forceful “pause” of the trial.
A spokesperson for the AstraZeneca vaccine said in a statement Tuesday that “we voluntarily paused vaccination to allow a review of safety data by an independent committee.
“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”
The company said that in large trials, illnesses will sometimes happen by chance but must be reviewed independently.
AstraZeneca didn’t offer further details, but medical news site Stat News, which first reported the volunteer’s illness, quoted a source saying it had involved a “serious adverse reaction” to the vaccine.
“While this is obviously not great news, remember that fully investigating adverse reactions is a part of large scale trials and essential to ensure trust in any vaccine. It will, however, mean that results will be delayed,” Harvard epidemiology expert Bill Hanage wrote on Twitter.
With billions of people around the world still suffering from the fallout of the pandemic and the global death toll nearing 900,000, a worldwide race for a vaccine is underway, with nine companies already in late-stage Phase 3 trials.
Worldwide infections to date now stand at more than 27 million, and more than 890,000 people have died from the disease.
Russia has already approved a vaccine, and research published in The Lancet medical journal last week said patients involved in early tests developed antibodies with “no serious adverse events.”
But scientists cautioned the trials were too small.
According to Stat News, the ill vaccine volunteer was likely participating in a Phase 2/3 trial based in the United Kingdom.
China, meanwhile, put its homegrown vaccines on display for the first time at a Beijing trade fair this week, and authorities hope the jabs will be approved for use by the end of the year.
The vaccines are among the handful to have entered Phase 3 trials.
Across Europe, concerns are growing about a resurgence of the virus, with France tightening restrictions, cases in Britain spiking and schools resuming around the region.
In China, however, the virus has been all but banished through lockdowns and travel restrictions earlier in the year that have officials touting the nation as a coronavirus success story.
China’s leaders staged a triumphant ceremony to celebrate beating the coronavirus on Tuesday, with President Xi Jinping stating that China had passed “an extraordinary and historic test” during an awards ceremony for medical professionals.
The nation’s propaganda machine has been attempting to seize the narrative surrounding the pandemic, reframing the episode as an example of the agility and organisation of the Communist leadership.
The economic fallout from the virus continues to wreak havoc on economies around the world, with governments desperate to get back to normality.
India pressed ahead with reopening despite surpassing Brazil on Monday as the second-most infected nation in the world, with more than 4.2 million cases.
